St. Jude Medical's Optis Mobile System Launched in Europe and Japan

February 8, 2016—St. Jude Medical, Inc. announced the launch of the company’s Optis mobile system in Europe and Japan. The diagnostic system is designed to couple optical coherence tomography and angiography coregistration with fractional flow reserve (FFR) technology into one portable system for hospitals with multiple catheterization labs.

According to St. Jude Medical, the latest Optis system offers physicians an efficient way to optimize percutaneous coronary intervention (PCI) procedures for the treatment of vascular disease by combining diagnostic tools designed to improve patient outcomes into one portable device.

The Optis mobile system is designed to help physicians make improved stenting decisions based on high-resolution and three-dimensional optical coherence tomography views of coronary anatomy while simultaneously mapping their exact location via angiography. The Optis mobile system also integrates St. Jude Medical PressureWire FFR measurement technology, which offers physicians detailed coronary hemodynamic information during PCI. Clinical data have shown the physiological measurements provided by St. Jude Medical FFR technology can improve outcomes and reduce health care costs over traditional diagnostic imaging tools, noted the company.

In the company’s announcement, Nick West, MD, of Papworth Hospital in Cambridge, United Kingdom, commented, “As the interventional cardiology landscape continues to expand, there is a real need for more portable intravascular imaging systems to ensure hospitals with multiple catheterization labs have the right technology available for physicians to make more informed treatment decisions during PCI. The imaging advancements offered with the Optis mobile system provide the same benefits of the Optis integrated system, and allow physicians to clearly visualize complex cardiac anatomy and evaluate how to best proceed during PCI.”